Sunday, May 09, 2010

Greece's Drug Price Cuts May Spread, Hitting Pharma Co Profits

"This 'parallel trade' is already a thorn in the side of the industry and will only be exacerbated by Greek price cuts," Ambrian analyst Mike Ward said in a note Thursday, adding that "similar unilateral governmental responses to the financial crisis in more significant markets such as Spain or the U.K. clearly would be unwelcome." Read more: http://www.nasdaq.com/aspx/company-news-story.aspx?storyid=201005060849dowjon...

Posted via web from Jack's posterous

No comments: